Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/5365
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHatip-Al-Khatib, Izzettin-
dc.contributor.authorBolukbaşi-Hatip, F.-
dc.date.accessioned2019-08-16T11:45:40Z
dc.date.available2019-08-16T11:45:40Z
dc.date.issued2002-
dc.identifier.issn0031-7012-
dc.identifier.urihttps://hdl.handle.net/11499/5365-
dc.identifier.urihttps://doi.org/10.1159/000063249-
dc.description.abstractHaloperidol is a typical antipsychotic drug with inhibitory effects on dopamine and calcium homeostasis. In this study, the effect of haloperidol on the inotropism of rabbits' isolated heart was investigated by measuring the isovolumetric left ventricular pressure using a balloon in a modified Langendorff perfusion apparatus. Haloperidol at 0.01-0.3 µmol/l induced a negative inotropic effect (Emax = 77.95 ± 0.19; EC50 = 0.043 ± 0.002 µmol/l). The effect of haloperidol was decreased by Ca2+ (Emax = 42.93 ± 3.22; EC50 = 0.37 ± 0.07 µmol/l; pD'2 = 7.01 ± 0.16), Bay K 8644 (Emax = 30.75 ± 1.33; EC50 = 10.43 ± 1.5 µmol/l, pD'2 = 7.13 ± 0.12), and digoxin (Emax = 42.03 ± 3.72, EC50 = 0.32 ± 0.05 µmol/l, pD'2 = 6.81 ± 0.14). The effect of haloperidol was also reduced by norepinephrine (Emax = 37.16 ± 1.84; EC50 = 1.73 ± 0.24 µmol/l, pD'2 = 6.97 ± 0.08) and dopamine (Emax = 35.68 ± 2.78; EC50 = 0.69 ± 0.01 µmol/l, pD'2 = 7.48 ± 0.15). However, the effect of haloperidol was nonsignificantly reduced by dobutamine (Emax = 58.89 ± 5.18; EC50 = 0.15 ± 0.06 µmol/l, pD'2 = 5.88 ± 0.47). These results show that the drugs that increase the influx of Ca2+ into the cardiomyocyte decrease the negative inotropic effect of haloperidol, suggesting that the effect of haloperidol could be mediated via mechanisms involving actions on Ca2+ entry into the cardiomyocyte. Haloperidol should be used carefully when prescribed for patients with cardiovascular disorders. Copyright © 2002 S. Karger AG, Basel.en_US
dc.language.isoenen_US
dc.relation.ispartofPharmacologyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCalciumen_US
dc.subjectHaloperidolen_US
dc.subjectIsolated hearten_US
dc.subjectNegative inotropismen_US
dc.subject1,4 dihydro 2,6 dimethyl 5 nitro 4 [2 (trifluoromethyl)phenyl] 3 pyridinecarboxylic acid methyl esteren_US
dc.subjectcalcium ionen_US
dc.subjectdigoxinen_US
dc.subjectdobutamineen_US
dc.subjectdopamineen_US
dc.subjecthaloperidolen_US
dc.subjectnoradrenalinen_US
dc.subjectcalciumen_US
dc.subjectcalcium channel stimulating agenten_US
dc.subjectcardiotonic agenten_US
dc.subjectneuroleptic agenten_US
dc.subjectanimal tissueen_US
dc.subjectapparatusen_US
dc.subjectarticleen_US
dc.subjectcalcium transporten_US
dc.subjectconcentration responseen_US
dc.subjectcontrolled studyen_US
dc.subjectdrug effecten_US
dc.subjectheart left ventricle pressureen_US
dc.subjectheart muscle cellen_US
dc.subjectheart muscle contractilityen_US
dc.subjectinotropismen_US
dc.subjectisolated hearten_US
dc.subjectmaleen_US
dc.subjectnonhumanen_US
dc.subjectpriority journalen_US
dc.subjectrabbiten_US
dc.subjectanalysis of varianceen_US
dc.subjectanimalen_US
dc.subjectchemical phenomenaen_US
dc.subjectdose responseen_US
dc.subjectheart contractionen_US
dc.subjectheart left ventricle functionen_US
dc.subjectheart ventricle pressureen_US
dc.subjectin vitro studyen_US
dc.subjectAnalysis of Varianceen_US
dc.subjectAnimalen_US
dc.subjectAntipsychotic Agents, Butyrophenoneen_US
dc.subjectBay-K-8644en_US
dc.subjectCalcium Channel Agonistsen_US
dc.subjectCardiotonic Agentsen_US
dc.subjectDepression, Chemicalen_US
dc.subjectDigoxinen_US
dc.subjectDobutamineen_US
dc.subjectDopamineen_US
dc.subjectDose-Response Relationship, Drugen_US
dc.subjectIn Vitroen_US
dc.subjectMaleen_US
dc.subjectMyocardial Contractionen_US
dc.subjectNorepinephrineen_US
dc.subjectRabbitsen_US
dc.subjectVentricular Function, Leften_US
dc.subjectVentricular Pressureen_US
dc.subject3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esteren_US
dc.subjectAnimalsen_US
dc.subjectAntipsychotic Agentsen_US
dc.titleModulation of the negative inotropic effect of haloperidol by drugs with positive inotropic effects in isolated rabbit hearten_US
dc.typeArticleen_US
dc.identifier.volume66en_US
dc.identifier.issue1en_US
dc.identifier.startpage19
dc.identifier.startpage19en_US
dc.identifier.endpage25en_US
dc.authorid0000-0002-9127-6779-
dc.identifier.doi10.1159/000063249-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.pmid12169761en_US
dc.identifier.scopus2-s2.0-0035995465en_US
dc.identifier.wosWOS:000177653800004en_US
dc.identifier.scopusqualityQ1-
dc.ownerPamukkale_University-
item.languageiso639-1en-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.grantfulltextnone-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

4
checked on Oct 13, 2024

WEB OF SCIENCETM
Citations

5
checked on Oct 8, 2024

Page view(s)

54
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.